GRB2 and cancer: The MBD Try1349 and 1356 provide a docking platform to recruit the Src homology-2 domain, phosphotyrosine-binding domain, and other critical MBD adapter proteins GAB1, GRB2, phospholipase C, and SRC required for activating cancer motility [27].